ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

Antman, 2008, J Am Coll Cardiol., 51, 210, 10.1016/j.jacc.2007.10.001

Anderson, 2007, J Am Coll Cardiol., 50, e1, 10.1016/j.jacc.2007.02.013

Grines, 2007, J Am Coll Cardiol., 49, 734, 10.1016/j.jacc.2007.01.003

Bavry, 2008, Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis, Lancet, 371, 2134, 10.1016/S0140-6736(08)60922-8

Antman, 2007, Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association, Circulation, 115, 1634, 10.1161/CIRCULATIONAHA.106.181424

Bhatt, 2006, NSAIDS and the risk of myocardial infarction: do they help or harm?, Eur Heart J, 27, 1635, 10.1093/eurheartj/ehl090

Antman, 2005, Cyclooxygenase inhibition and cardiovascular risk, Circulation, 112, 759, 10.1161/CIRCULATIONAHA.105.568451

Abraham, 2005, National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs, Gastroenterology, 129, 1171, 10.1053/j.gastro.2005.08.003

Talley, 1995, Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly, Dig Dis Sci., 40, 1345, 10.1007/BF02065549

Shaheen, 2006, The burden of gastrointestinal and liver diseases, 2006, Am J Gastroenterol., 101, 2128, 10.1111/j.1572-0241.2006.00723.x

Lawrence, 1998, Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States, Arthritis Rheum., 41, 778, 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V

Scheiman, 1996, NSAIDs, gastrointestinal injury, and cytoprotection, Gastroenterol Clin North Am., 25, 279, 10.1016/S0889-8553(05)70247-8

Lanas, 2007, Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment, Curr Med Res Opin., 23, 163, 10.1185/030079907X162656

Wallace, 2000, NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2, Gastroenterology, 119, 706, 10.1053/gast.2000.16510

Cox, 2004, Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users, Arch Intern Med., 164, 1243, 10.1001/archinte.164.11.1243

Abraham, 2007, Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident, Aliment Pharmacol Ther., 25, 913, 10.1111/j.1365-2036.2007.03292.x

Ma, 2001, Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release, Proc Natl Acad Sci U S A, 98, 6470, 10.1073/pnas.111150798

Kabbinavar, 2003, Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer, J Clin Oncol., 21, 60, 10.1200/JCO.2003.10.066

Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis: VIGOR Study Group, N Engl J Med., 343, 1520, 10.1056/NEJM200011233432103

Griffin, 1988, Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons, Ann Intern Med., 109, 359, 10.7326/0003-4819-109-5-359

Griffin, 1991, Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons, Ann Intern Med., 114, 257, 10.7326/0003-4819-114-4-257

Smalley, 1995, Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons, Am J Epidemiol., 141, 539, 10.1093/oxfordjournals.aje.a117469

Hawkey, 2007, Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies, Arthritis Res Ther., 9, R17, 10.1186/ar2124

Ofman, 2002, A meta-analysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs, J Rheumatol., 29, 804

Singh, 1999, Epidemiology of NSAID induced gastrointestinal complications, J Rheumatol Suppl., 56, 18

Abraham, 2008, National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use, Aliment Pharmacol Ther., 28, 97, 10.1111/j.1365-2036.2008.03706.x

Fries, 2004, The rise and decline of nonsteroidal anti-inflammatory drug-associated gastropathy in rheumatoid arthritis, Arthritis Rheum., 50, 2433, 10.1002/art.20440

Hallas, 2006, Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study, BMJ, 333, 726, 10.1136/bmj.38947.697558.AE

Johnson, 2005, Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist, Rev Cardiovasc Med, 6, S15

Abraham, 2008, Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users, Am J Gastroenterol., 103, 323, 10.1111/j.1572-0241.2007.01595.x

Lanas, 2000, Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding, N Engl J Med., 343, 834, 10.1056/NEJM200009213431202

Scheiman, 2007, Summing the risk of NSAID therapy, Lancet, 369, 1580, 10.1016/S0140-6736(07)60722-3

Pearson, 2002, AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases, Circulation, 106, 388, 10.1161/01.CIR.0000020190.45892.75

Mosca, 2007, Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update, Circulation, 115, 1481, 10.1161/CIRCULATIONAHA.107.181546

Hayden, 2002, Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force, Ann Intern Med., 136, 161, 10.7326/0003-4819-136-2-200201150-00016

Chan, 2004, Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications–review and recommendations based on risk assessment, Aliment Pharmacol Ther., 19, 1051, 10.1111/j.1365-2036.2004.01935.x

Weil, 1995, Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, 310, 827, 10.1136/bmj.310.6983.827

Yeomans, 2005, Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin, Aliment Pharmacol Ther., 22, 795, 10.1111/j.1365-2036.2005.02649.x

de Abajo, 2001, Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations, BMC Clin Pharmacol., 1, 1, 10.1186/1472-6904-1-1

Kelly, 1996, Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product, Lancet, 348, 1413, 10.1016/S0140-6736(96)01254-8

McQuaid, 2006, Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials, Am J Med., 119, 624, 10.1016/j.amjmed.2005.10.039

Hernandez-Diaz, 2006, Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications, BMC Med., 4, 22, 10.1186/1741-7015-4-22

Sorensen, 2000, Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin, Am J Gastroenterol., 95, 2218, 10.1111/j.1572-0241.2000.02248.x

Wilcox, 1994, Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage, Arch Intern Med., 154, 42, 10.1001/archinte.1994.00420010064008

Derry, 2000, Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis, BMJ, 321, 1183, 10.1136/bmj.321.7270.1183

Laine, 2005, Bleeding complications related to aspirin dose, Am J Cardiol., 96, 1035, 10.1016/j.amjcard.2005.06.011

Serebruany, 2005, Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials, Am J Cardiol., 95, 1218, 10.1016/j.amjcard.2005.01.049

2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71

Peters, 2003, Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study, Circulation, 108, 1682, 10.1161/01.CIR.0000091201.39590.CB

Garcia Rodriguez, 2001, Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies, Br J Clin Pharmacol., 52, 563, 10.1046/j.0306-5251.2001.01476.x

Berger, 2008, Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy, Circulation, 117, 192, 10.1161/CIRCULATIONAHA.107.729558

King, 2008, J Am Coll Cardiol., 51, 172, 10.1016/j.jacc.2007.10.002

Eikelboom, 2007, Combined antiplatelet and anticoagulant therapy: clinical benefits and risks, J Thromb Haemost, 5, 255, 10.1111/j.1538-7836.2007.02499.x

Lanas, 2003, Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs, Eur J Gastroenterol Hepatol., 15, 173, 10.1097/00042737-200302000-00011

Taha, 2005, Upper gastrointestinal haemorrhage associated with low-dose aspirin and antithrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs, Aliment Pharmacol Ther., 22, 285, 10.1111/j.1365-2036.2005.02560.x

Younossi, 1997, Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding, Dig Dis Sci., 42, 79, 10.1023/A:1018833021039

Collins, 1996, Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials, BMJ, 313, 652, 10.1136/bmj.313.7058.652

1996, Low-molecular-weight heparin during instability in coronary artery disease, Lancet, 347, 561, 10.1016/S0140-6736(96)91270-2

Yusuf, 2005, Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation, JAMA, 293, 427, 10.1001/jama.293.4.427

Andreotti, 2006, Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients, Eur Heart J, 27, 519, 10.1093/eurheartj/ehi485

Hirsh, 2008, Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 71, 10.1378/chest.08-0693

1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

Bhatt, 2000, Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin, Am Heart J, 140, 67, 10.1067/mhj.2000.108239

Gluckman, 2004, A practical and evidence-based approach to cardiovascular disease risk reduction, Arch Intern Med., 164, 1490, 10.1001/archinte.164.14.1490

Grines, 2007, Circulation, 115, 813, 10.1161/CIRCULATIONAHA.106.180944

Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med., 345, 494, 10.1056/NEJMoa010746

Diener, 2004, Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial, Lancet, 364, 331, 10.1016/S0140-6736(04)16721-4

Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med., 354, 1706, 10.1056/NEJMoa060989

Bhatt, 2007, Intensifying platelet inhibition–navigating between Scylla and Charybdis, N Engl J Med., 357, 2078, 10.1056/NEJMe0706859

Bavry, 2007, Drug-eluting stents: dual antiplatelet therapy for every survivor?, Circulation, 116, 696, 10.1161/CIRCULATIONAHA.107.719484

Sheikh, 2002, Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls, J Clin Gastroenterol., 34, 529, 10.1097/00004836-200205000-00009

Fork, 2000, Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers: a gastroscopic study, Scand J Gastroenterol., 35, 464, 10.1080/003655200750023705

Lanas, 2006, Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations, Gut, 55, 1731, 10.1136/gut.2005.080754

Chan, 2005, Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding, N Engl J Med., 352, 238, 10.1056/NEJMoa042087

Lai, 2006, Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications, Clin Gastroenterol Hepatol., 4, 860, 10.1016/j.cgh.2006.04.019

Lanas, 2007, Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants, Am J Gastroenterol., 102, 507, 10.1111/j.1572-0241.2006.01062.x

Anand, 2007, Oral anticoagulant and antiplatelet therapy and peripheral arterial disease, N Engl J Med., 357, 217, 10.1056/NEJMoa065959

Khurram, 2006, Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding, J Invasive Cardiol., 18, 162

Donnelly, 2000, Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury, Aliment Pharmacol Ther., 14, 529, 10.1046/j.1365-2036.2000.00739.x

Goldstein, 2004, Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis, Clin Ther., 26, 1637, 10.1016/j.clinthera.2004.10.002

Silverstein, 1995, Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial, Ann Intern Med., 123, 241, 10.7326/0003-4819-123-4-199508150-00001

Kitchingman, 1989, Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine, Br J Clin Pharmacol., 28, 581, 10.1111/j.1365-2125.1989.tb03545.x

Cole, 1992, Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin, Aliment Pharmacol Ther., 6, 707, 10.1111/j.1365-2036.1992.tb00735.x

Chin, 2007, Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study, Am J Gastroenterol., 102, 2411, 10.1111/j.1572-0241.2007.01460.x

Lai, 2002, Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use, N Engl J Med., 346, 2033, 10.1056/NEJMoa012877

Chan, 2001, Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen, N Engl J Med., 344, 967, 10.1056/NEJM200103293441304

Lanas, 2003, Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole, Scand J Gastroenterol., 38, 693, 10.1080/00365520310003967

Scheiman, 2006, Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors, Am J Gastroenterol., 101, 701, 10.1111/j.1572-0241.2006.00499.x

Gilard, 2008, Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study, J Am Coll Cardiol., 51, 256, 10.1016/j.jacc.2007.06.064

Trenk, 2008, Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents, J Am Coll Cardiol., 51, 1925, 10.1016/j.jacc.2007.12.056

Lanas, 2002, Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin, Aliment Pharmacol Ther., 16, 779, 10.1046/j.1365-2036.2002.01230.x

Stack, 2002, Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding, Aliment Pharmacol Ther., 16, 497, 10.1046/j.1365-2036.2002.01197.x

Chan, 2005, Long-term incidence of ulcer bleeding with low-dose aspiring after eradication of H, Gastroenterology, 128, A133

Chey, 2007, American College of Gastroenterology guideline on the management of Helicobacter pylori infection, Am J Gastroenterol., 102, 1808, 10.1111/j.1572-0241.2007.01393.x

Dorward, 2006, Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding, Cochrane Database Syst Rev.

Green, 1978, Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor prolonged gastroduodenal mucosal hemorrhage, Gastroenterology, 74, 38, 10.1016/0016-5085(78)90352-9

Sung, 2008, Can aspirin be reintroduced with PPI inhibitor INFUSION after endoscopic hemostatis: a double-blinded randomized controlled trial, Gastroenterology, 130, A44

Eisen, 2002, Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures, Gastrointest Endosc., 55, 775, 10.1016/S0016-5107(02)70402-1